DOCSLIB.ORG

Scientific Program January 26-27, 2021 All Program Times in IST Time Zone (CET+1)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Scientific Program January 26-27, 2021 All Program Times in IST Time Zone (CET+1) Scientific Program January 26-27, 2021 All program times in IST time zone (CET+1) Tuesday, January 26 Hall A 10:15-10:35 Gathering and Exhibition 10:35-12:00 Session 1: Opening Plenary Session Chairs: Haim Shirin; Oren Shibolet 10:35-10:45 Welcome address Haim Shirin Shamir Medical Center (Assaf Harofeh) 10:45-11:30 Hepatitis C: The beginning, the middle and possibly the end (Supported by Gilead) Harvey Alter 2020 Nobel Prize laureate University of Rochester School of Medicine, Rochester, New York, USA 11:30-12:00 IBD Treatment Paradigm – Future Evolution and Agility - LIVE (Supported by Takeda) Laurent Peyrin-Biroulet Gastroenterology Department, Nancy University Hospital, France 12:00-12:15 Break Hall A Hall B 12:15-13:30 Session 2: Neurogastroenterology and Motility 12:15-13:30 Session 3: Obesity Treatment – How? Who? When? Chairs: Chairs: Roy Dekel; Fabiana Benjaminov, Meir Medical Center; Anat Nevo-Shor, Soroka University Medical Center TBA 12:15-12:20 Brief Introduction: Roy Dekel 12:15-12:30 Weight loosing medications: The Israeli status Liat Barzilay Yoseph Endocrinology Department, Meir Medical Center 12:20-12:30 Take a big breath: New Guidelines for the clinical use of Breath Tests – 12:30-12:50 Endoscopic bariatric treatments- Where do we stand? Lessons from The Israeli Consensus Group Reem Sharaiha Ram Dickman Weill Cornell Medicine, Division of Gastroenterology and Hepatological Rabin Medical Center Department of Medicine, New York, USA 12:30-12:45 IBS – What are the underlying mechanisms - an update on IBS 12:50-13:00 Future directions in bariatric endoscopy pathophysiology Ian Gralnek Guy Boeckxstaens Gastroenterology and Hepatology Department, Haemek Medical Center Translational Research Center for GI Disorders (TARGID), University Hospital Leuven 12:45-13:00 IBS – New drugs and future directions What's in the pipeline: what are 13:00-13:15 Panel discussion: Who should treat the obese patient? the most promising new drugs in FGID Panel: Jan Tack Liat Barzilay Department of Gastroenterology University Hospitals Leuven, Belgium Sigal Fishman, Department of Gastroenterology, Tel Aviv Sourasky Medical Center Steven Shama, Rabin Medical Center Reem Sharaiha 13:00-13:05 The Israeli Neurogastroenterology Group is here for you: A Practical 13:15-13:22 Endoscopic ultrasound (EUS) guided radiofrequency ablation (RFA) for approach for the treatment IBS – Position paper pancreatic neuroendocrine tumors (pNET): are the results still good when based Roy Dekel on PET-CT ga68 follow up? Sourasky Medical Center, Ichilov Hospital Joel Schifter1; Alain Dancour2; Genadi, Sheykman2; Menachem Ben Haim2; Eran Goldin2; Dan M. Livovsky2 1Shaare Tzedek Medical Center, 2Digestive Diseases Institute Shaare Zedek Medical Center 13:05-13:12 THE NATURAL HISTORY OF ESOPHAGEAL "ABSENT CONTRACTILITY" AND 13:22-13:30 SAFE WITH HIGH CLINICAL IMPACT: PRELIMINARY RESULTS ITS RELATIONSHIP WITH RHEUMATOLOGIC DISEASES: A CASE-CONTROL Dov Wengrower; Mahmoud Mahamid; Eran Goldin STUDY WITH LONG-TERM FOLLOW-UP Digestive Disease Institute,Shaare Zedek Medical Center, affiliated to the Daniel Cohen; Anton Bermont; Vered Richter; Haim Shirin Henrew University Medical School Shamir (Assaf Harofeh) Medical Center 13:12-13:20 POSITIVE FINDINGS ON VIDEO CAPSULE ENDOSCOPY HAS A MINOR LONG-TERM THERAPEUTIC IMPACT IN PATIENTS WITH IRON DEFICIENCY ANEMIA Anton Bermont; Daniel Cohen; Efrat Broide; Vered Rihter; Haim Shirin The Gonczarowski Family Institute of Gastroenterology and Liver Diseases, Shamir Medical Center 13:20-13:30 Live Q&A 13:30-13:45 Break Hall A Hall B 13:45-15:20 Session 4: Hepatology 13:45-15:20 Session 5: IBD Chairs: Chairs: Ayelet Partoush Abbou, Bnai Zion Medical Center Yehuda Chowers, Gastroenterology Department, Rambam Health Care Campus; Rifaat Safadi; Vered Richter, Shamir (Assaf Harofeh) Medical Center 13:45-14:05 How Cholestasis Patients Scratch in 2021? 13:45-14:10 Pre-IBD diagnosis: Why should we do it and where are we now? Rifaat Safadi Johanna Torres Hadassah-Hebrew University Medical Center Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal 14:05-14:25 Hepatocellular Carcinoma, A Breakthrough After All These Years 14:10-14:35 Current status of combination treatments in IBD (Supported by Roche( Remo Panaccione Oren Shibolet Inflammatory Bowel Disease Clinic, Cumming School of Medicine, University of Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University Calgary, Canada 14:25-14:45 Immune Mediated DILI of Biologic Therapies & Checkpoints 14:35-14:55 TBA Assaf Issachar Rabin Medical Center 14:45-14:52 CHRONIC HEPATITIS B INFECTION AND DIABETES MELLITUS: A DOUBLE 14:55-15:02 THE COURSE OF COVID-19 IN IBD PATIENTS TREATED WITH BIOLOGICS LIVER TROUBLE? Fadi Abu Baker1; Ilan Green2; Gadeer Taha2; Yana Davidov3; Tawfik Lev Lichtenstein1; Benjamin Koslowsky2; Irit Avni-Biron3; Baruch Ovadia4; Ofer Khoury4; Amir Mari4; Yael Kopelman1; Saif Abu Mouch1; Ziv Ben Ari3 Ben-Bassat5; Timna Naftali6; Uri Kopylov7; Yael Haberman-Ziv8; Hagar Banai- 1Hillel Yaffe Meidcal Center, 2Leumit Health Care Services, 3Sheba Eran9; Rami Eliakim7; Adi Lahat-Zok7; Ayal Hirsch10; Eran Zittan11; Nitsan Medical Center, 4EMMS Medical Center Maharshak10; Matti Waterman12; Eran Israeli13; Idan Goren9; Jacob E. Ollech9; Henit Yanai9; Bella Ungar7; Benjamin Avidan7; Dana Ben Hur12; Bernardo Melamud13; Ori Segol14; Zippora Shalem15; Iris Dotan9; Selwyn H. Odes16; Shomron Ben-Horin7; Yf'at Snir9; Yael Milgrom17; Efrat Broide15; Eran Goldin18; Shmuel Delgado19; Yulia Ron10; Nathaniel Aviv Cohen10; Eran Maoz20; Mia Zborovski20; Safwat Odeh21; Naim Abu Freha22; Eyal Shachar7; Yehuda Chowers12; Tal Engel7; Hila Reiss16; Arie Segal22; Adar Zinger17; Ariella Bar-Gil Shitrit2,18 1Ben-Gurion University, 2Hebrew University, 3Tel Aviv University, 4Hillel Yaffe Medical Center, 5Barzilai Medical Center, 6Meir Medical Center, 7The Chaim Sheba Medical Center, 8Safra Medical Center, 9Rabin Medical Center, 10Tel Aviv Sourasky Medical Center (Ichilov), 11Emek Medical Center, 12Rambam Medical Center, 13Wolfson Medical Center, 14Lady Davis Carmel Medical Center, 15Shamir Medical Center (Assaf Harofeh), 16Mayanei HaYeshua Medical Center, 17Hadassah Medical Center, 18Shaare Zedek Medical Center, 19Samson Assuta Medical Center, 20Clalit Health Services, 21Bnai Zion Medical Center, 22Soroka Medical Center 14:52-15:12 HCV Extra Hepatic Manifestations, where are the patients? 15:02-15:12 Position statement of the Israeli IBD society on treatment strategies 2021 (Supported by Abbvie( Henit Yanai Ziv Ben Ari Rabin Medical Center Sheba Medical Center, Sackler School of Medicine, Tel Aviv University 15:12-15:20 ELEVATED PRE COVID-19 FIB-4 AS A GOOD BIOMARKER OF COVID-19 15:12-15:20 EFFECTIVNES OF TOFACITINIB IN A REAL-WORLD ISRAELI COHOT OF PATIENTS INFECTION OUTCOME WITH MODERATE - SEVERE ULCERATIVE COLITIS Yael Milgrom1; Asher Shafrir1; Eliana Meshrky1; David Hakimian1; Irit Avni Biron1; Ariella Bar-Gil Shitrit2; Binyamin Koslowsky2; Assaf Levartovsky3; Mohamad Masarowahr1; Rifaat Safadi1; Michal Shauly-Aharonov2 Ronny Weisshof4; Nathaniel Aviv Cohen5; David Hovel6; Timna Naftali7; Idan 1Hadassah Medical Center, 2Hebrew University Goren1; Ifat Snir1; Hagar Banai1; Jacob Ollech8; Yelena Broytman8; Iris Dotan8; Henit Yanai8 1IBD Center, Division of Gastroenterology, Rabin Medical Center, 2Digestive Diseases Institute, Shaare Zedek Medical Center, 3Department of Gastroenterology and Liver Diseases, Sheba Medical Center, 4Gastroenterology Institute, Rambam Health Care Campus, 5IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, 6Department of Gastroenterology and Liver Diseases, Edith Wolfson Medical Center, 7Department of Gastroenterology and Liver Diseases, Meir Medical Center, 8IBD Center, Division of Gastroenterology, Rabin Medical Center 15:20-15:25 Break Hall A 15:25-16:10 Experts Session: Small molecules for ulcerative colitis – learn from the past anticipate for the future (Sponsored by BMS) TBA Wednesday, January 27 10:30-11:00 – Business meeting of the Israeli Society of Gastroenterology and Liver Diseases Hall A Hall B 11:00-12:15 Session 6: Moderate-severe uncomplicated (also complicated) Crohn's 11:00-12:15 Session 7: Malignancies disease that you see in your everyday clinic Chairs: (Supported by Janssen) Naim Abu-Freha; Chairs: Zohar Levi Iris Dotan; Dan Turner 11:00-11:15 Moderate-severe uncomplicated Crohn's disease - challenges and 11:00-11:10 The impact of COVID-19 on screening for CRC in Europe and the US therapies Nathan Gluck Iris Dotan GI Malignancy Unit, Department of Gastroenterology, Sackler School of Rabin Medical Center Medicine, Tel Aviv University 11:15-11:30 The approach to newly diagnosed Crohn’s disease: what every clinician 11:10-11:20 What every gastroenterologist should know about the new Israeli guidelines should know in 2021 concerning Lynch Syndrome David Rubin Zohar Levi University of Chicago, Illinois, USA Rabin Medical Center 11:30-11:45 Penetrating disease? The surgeon can wait! Sometimes 11:20-11:30 New non-invasive methods for early detection of CRC Dan Turner Elez Vainer Shaare Zedek Medical Center, The Hebrew University of Jerusalem Hadassah-Hebrew University Medical Center 11:45-12:00 Q&A panel 11:30-11:37 GENETIC TESTING FOR ASSESSMENT OF LYNCH SYNDROME IN YOUNG PATIENTS WITH POLYPS Ido Laish1;Yael Goldberg2; Eitan Friedman3; Lior Katz4; Zohar Levi5; Uri Kopylov1; Dan Feldman6; Gili Reznick Levi7; Elizabeth Half8 1Gastroenterology Institute, Chaim Sheba Medical Center, 2Recanati
Load more

Recommended publications
  • Scientific Program
    www.iscort.org.il Scientific Program 08.01.2019 - 12.01.2019, Eilat, Israel The Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies הוועדה המארגנת for their support of the 19th ISCORT Annual Meeting: Organizing Committee ISCORT 19 נשיא הכנס: :President פרופ׳ סלומון שטמר Platinum Sponsor Salomon M. Stemmer, MD Roche מזכירת הכנס: :Secretory ד״ר ולריה סמניסטי Gold Sponsor Valeria Semenysty, MD יו"ר הרדיותרפיה: :BMS Radiation Oncology Co-Chair פרופ׳ בן קורן MSD Ben W. Corn, MD הוועדה המדעית Silver Sponsor Scientific Committee ISCORT 19 Astellas יו"ר: פרופ׳ מיכל לוטם Astrazeneca Chairman: Michal Lotem, MD ד"ר אהרון אלון Boehringer Ingelheim Aaron Allen, MD ד"ר נועם אסנה Eli Lilly Noam Asna, MD ד"ר יאיר בר ISI Jair Bar, MD PhD ד"ר יהונתן כהן Novartis Yonathan Cohen, MD PhD פרופ׳ בן קורן Pfizer Ben W. Corn, MD ד"ר אלה עברון Rafa Ella Evron, MD ד"ר דניאלה כץ Daniela Katz, MD פרופ׳ גל מרקל Bronze Sponsor Gal Markel, MD PhD ד"ר אינה אוספובט AbbVie Inna Ospovat, MD ד"ר אביבית פאר Assuta Avivit Peer, MD ד"ר רות פרץ Bayer Ruth Perets, MD PhD Bolpharma ד"ר רפאל פפר Raphael Pfeffer, MD Dexcel Pharma ד"ר קרן רובינוב Keren Rouvinov, MD Isotopia ד"ר יקטרינה שולמן Katerina Shulman, MD Medison ד"ר אמיר זוננבליק Merck Amir Sonnenblick, MD ד"ר מרק ויגודה Nanostring Marc Wygoda, MD ד"ר אלונה זר Neopharm Alona Zer, MD ד"ר אביעד זיק Oncotest-Teva Aviad Zik, MD Perrigo החברה המארגנת Sanofi Organizing Company א.מ.
    [Show full text]
  • Israel Endocrine Society
    Israel Endocrine Society Israel Endocrine Society Conference Browse the program for the upcoming event By Session All Sessions By ID 4 By Day Tuesday By Author Aizic, A. - 31 Now Viewing: All Sessions Note: The presenter's name is in bold Registration Tuesday Morning Date: Tuesday, April 9, 2013 Time: 7:30 AM - 8:00 AM Location: Oral Presentations I: Diabetes, Obesity and Metabolism Date: Tuesday, April 9, 2013 Time: 8:00 AM - 10:00 AM Location: Bareket Hall Session Chair: Benjamin Glaser Session Chair: Hannah Kanety 8:00 AM - AMPK corrects ER morphology and function in stressed pancreatic beta-cells via regulation of the ER resident protein DRP1 (ID: 25) Jakob Wikstrom (Israel) Tal Israeli (Israel) Etty Bachar-Wikstrom (Israel) Yafa Ariav (Israel) Erol Cerasi (Israel) Gil Leibowitz (Israel) 8:15 AM - Paradox In Metabolic Homeostasis: AHNAK Knockout Mice Are Resistant To Diet-Induced Obesity And Yet They Display Reduced Insulin Sensitivity (ID: 47) Maya Ramdas (Israel) Chava Harel (Israel) Natalia Krits (Israel) http://www.xcdsystem.com/ies2013/Program/index.cfm[05/04/2013 11:15:55] Israel Endocrine Society Michal Armoni, Rambam Medical Center (Israel) Eddy Karnieli, Institute of Endocrinology, Metabolism and Diabetes (Israel) 8:30 AM - Neonatal Wolfram syndrome: novel De-novo dominant mutation presenting as an unusual clinical phenotype (ID: 52) Abdulsalam Abu-Libdeh, Hadassah Hebrew University Hospital (Israel) 8:45 AM - Importance of maintaining redox potential balance in the development of type 2 diabetes (ID: 61) Tovit Rosenzweig,
    [Show full text]
  • Recurrent Deep Venous Thrombosis in a Patient with Agenesis of Inferior Vena Cava
    International Journal of General Medicine Dovepress open access to scientific and medical research Open Access Full Text Article CASE REPORT Recurrent deep venous thrombosis in a patient with agenesis of inferior vena cava William Nseir1 Background: Agenesis of the inferior vena cava (IVC) as a cause of recurrent deep vein Mahmud Mahamid1 thrombosis (DVT) is uncommon. Zuhair Abu-Rahmeh2 Case: A 33-year-old male with no family history of thrombophilia, who had experienced mul- Arieh Markel3,4 tiple recurrent episodes of DVT over a 15-year period of unknown cause, was admitted into our hospital because of cellulitis in the right leg. Computer tomography with contrast of the 1Department of Internal Medicine, 2Radiology Department, Holy abdomen showed an absence of IVC. Family Hospital, Nazareth, Israel; Conclusion: Congenital absence of the IVC could be a rare risk factor for idiopathic DVT, 3 Department of Internal Medicine A, especially in young individuals. Haemek Medical Center, Afula, Israel; 4Technion, Faculty of Medicine, Haifa, Keywords: deep vein thrombosis, agenesis, inferior vena cava Israel Background Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, has an incidence of 1 to 3 per 1000 individuals per year in Western populations.1 Congenital anomalies of the inferior vena cava (IVC) are uncommon, and have been associated with the development of venous thrombosis of the lower limbs.2 Congenital anomalies of the IVC has been reported as a risk factor for DVT, especially in individuals ,30 years old, and a concomitant thrombophilic disorder has been found in such individuals.3 We report a case of recurrent DVT in a 33-year-old man with agenesis of the IVC.
    [Show full text]
  • Curriculum Vitae – Barak Zafrir
    Curriculum Vitae – Barak Zafrir PERSONAL DETAILS Date Prepared: November 2016 Name: BARAK ZAFRIR Office Address: Cardiovascular Department, Lady Davis Carmel Medical Center 7 Michal St., Haifa, Israel. Home Address: 6/6 Moshe Dayan St. , Kiryat Tiveon , Israel Phone: +972-0522541577 Email: [email protected] FAX: +972-99560390 Place of Birth: ISRAEL Date of Birth June 11, 1974 Marital Status Married; 2 Children ACADEMIC DEGREES Faculty of Medicine, Technion, 1996-2002 M.D Medicine Israel Institute of Technology, Haifa, Israel. PROFESSIONAL EXPERIENCE 2015-present Director, Cardiac Prevention and Rehabilitation Service Carmel Medical Center, Haifa, Israel 2013-present Preventive Cardiology / Lipid Clinics (a) Carmel Medical Center, Haifa, Israel. (b) Acre, Clalit Health Services, Haifa and Western Galilee District. 1 2012-2013 Advanced Clinical/Research Fellowship: Preventive Cardiology and Cardio-metabolic Diseases Brigham & Women's Hospital, Harvard Medical School, Boston, USA, [Fellowship Director: Jorge Plutzky M.D] 2010-present Staff Cardiologist Cardiovascular Department, Carmel Medical Center, Haifa, Israel 2004-2010 Residency and Fellowship: Internal Medicine and Cardiology Carmel Medical Center, Haifa, Israel. 2003 Internship: Medicine and Surgery HaEmek Medical Center, Afula, Israel. PROFESSIONAL COURSES Oct. 2016 Advanced Course on Familial Hypercholesterolemia, European Atherosclerosis Society, Greece Dec. 2015 Hyperlipidemia Academy, Amgen Co., Geneva, Switzerland. Nov. 2014 Cardiopulmonary Exercise Testing Training Course,
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • THE ITALIAN-ISRAELI SUMMIT in CANCER PREVENTION and INTERVENTION June 3RD, 2015 TEL AVIV MEDICAL CENTER
    THE ITALIAN-ISRAELI SUMMIT IN CANCER PREVENTION AND INTERVENTION June 3RD, 2015 TEL AVIV MEDICAL CENTER SCIENTIFIC PROGRAM 08:00 Registration 08:45-09:00 Opening Session OPENING AND GREETINGS Cesare Hassan, Rome, Italy Nadir Arber, Tel Aviv, Israel Erwin Santo, Tel Aviv, Israel 09:00-10:20 Session I Chairs: Cesare Hassan, Italy Elizabeth Half, Israel 09:00 INTERVAL AND MISSED COLORECTAL Carlo Senore Torino, Italy 09:20 NOVEL TECHNOLOGIES OF SCREENING COLONOSCOPY Spada Cristiano, Digestive Endoscopy, Italy 09:40 A pro-active model to identify patients at high risk for familial cancer syndromes Tomer Adar, Shaare-Zedek, Jerusalem, Israel 10:00 CANCER PREVENTION IN LYNCH SYNDROME- IS IT POSSIBLE? Elizabeth Half Rambam Medical Center, Haifa, Israel 10:20 Coffee Break Session II 10:40-13:00 Chairs: Lorenzo Fuccio, Italy Yaron Niv, Israel 10:40 UNIVERSAL SCREENING FOR LYNCH SYNDROME- FEASABILITY AND MUTATIONAL STATUS IN ISRAEL Zohar Levi Rabin Medical Center, Petach Tiqva, Israel 11: 00 WHEN AND HOW TO PERFORM GENETIC TESTING FOR INHERITED POLYPOSIS SYNDROMES Revital Kariv Tel-Aviv Sourasky Medical Center, Israel 11:20 THE CLINICAL APPROACH TO PANCREATIC INCIDENTALOMA Erwin Santo Tel-Aviv Sourasky Medical Center, Israel 11:40 H. PYLORI ERADICATION IN THE PREVENTION OF GASTRIC CANCER Lorenzo Fuccio Gastroenterology Department, University of Bologna, Italy 12:00 HCC steps forward, but still a long way to go Oren Shibolet Liver Unit, Tel-Aviv Medical Center, Tel-Aviv, Israel 12:20 HEREDITARY diffuse gastric cancer Lior Katz Chaim Sheba Medical Center, Tel Hashomer, Israel 12:40 THE ENDOSCOPIC APPROCH TO EARLY BARRETT'S CANCER Fred Konikoff Meir Medical Center, Kfar-Saba, Israel 13:00-13:40 Lunch Break Session III 13:40-14:40 THE INVENTOR’S CORNER Chairs: Erwin Santo, Israel Cristiano Spada, Italy 13:40 WHY IS ISRAEL AN INOVATIVE COUNTRY? Ori Segol Carmel Medical Center, Haifa, Israel 13:50 FULL-SPECTRUM ENDOSCOPY (FUSE) Ian M.
    [Show full text]
  • Neuro-Ophthalmology in Israel
    Worldwide Neuro-Opthalmology Section Editor: Kathleen B. Digre, MD Neuro-Ophthalmology in Israel Ruth Huna-Baron, MD, Eitan Zvi Rath, MD FIG. 1. Pioneers of neuro-ophthalmology in Israel. euro-ophthalmology was introduced in Israel during challenge of the rapid development of new and expensive N the late 1970s by Riri Manor, Yochanan Goldhammer, diagnostic and therapeutic modalities, a committee of the and Isaac Gutman (Fig. 1). They trained with from William Ministry of Health each year announces new technologies Hoyt, Lawton Smith, and Myles Behrens, respectively. These and therapies to be included in basic health coverage. There pioneers trained many local ophthalmologists, neurologists, are 18 magnetic resonance imaging devices in Israel and 5 and neuro-ophthalmologists in Israel, and their efforts resulted interventional neurovascular units, and most medical in 21 neuro-ophthalmologists currently serving a population centers in the country have a neuro-ophthalmology service of 8 million. Many Israeli neuro-ophthalmologists did fellow- (Table 1). Much like in the United States, referrals come ships in the United States with a variety of other mentors, from neurologists, ophthalmologists, neurosurgeons inter- including Ronald Burde, Joel Glaser and Norman Schatz, ventional neuroradiologists, and endocrinologists. Mark Kupersmith, Byron Lam, Neil Miller, Barry Scarf, In 1997, the Israeli Neuro-Ophthalmology Society was and Jonathan Trobe. founded by Ririo Manor as a subspecialty section of the In Israel, each citizen is entitled to health care services Israeli Ophthalmology Society. Two annual meetings are under the National Health Insurance Law. To meet the organized by the society, of which one hosts a leading TABLE 1.
    [Show full text]
  • Determinants of Pulmonary Artery Pressure in Patients with Aortic Valve Stenosis
    S16 - Imaging in Valvular Disease Determinants of Pulmonary Artery Pressure in Patients with Aortic Valve Stenosis Diab Mutlak, Doron Aronson, Jonathan Lessick, Shimon Reisner, Salim Dabbah, Yoram Agmon Cardiology, Non-invasive Cardiology, Rambam Health Care Campus, Technion - Israel Insitute of Technology, Haifa, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 91 S16 - Imaging in Valvular Disease The Role of ECG - gated MDCT in the Evaluation of Aortic and Mitral Mechanical Valves Eli Konen 1,Orly Goitein1, Micha Feinberg 2,Yael Eshet2, Ehud Raanani 3, Shlomi Matetzky 2, Elio Di Segni 1,2 1 Diagnostic Imaging, Diagnostic Imaging, 2 Heart Institute, Heart Institute, 3 Dept. of Cardiac Surgery, Tel Aviv University, Tel Aviv, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 92 S16 - Imaging in Valvular Disease Aortic Valvuloplasty for Symptomatic Non-Surgical Aortic Stenosis with Concomitant Regurgitation - Indication or Contra-Indication? Moshe Rav-acha, Boris Varshitski, Ronen Beeri, Dan Gilon, Muchamad Afifi, Chaim Lotan, Haim D Danenberg Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 93 S16 - Imaging in Valvular Disease Functional Mitral Regurgitation Assessed by Echocardiographic Sphincter Index Yoav Turgeman, Alexander Feldman, Sandra Sagas, Limor Ilan- Bushari, Lev Bloch Heart Institute, HaEmek Medical Center, Afula, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 94 S17 - Pediatric Cardiology
    [Show full text]
  • Invasive Pneumococcal Disease in Young Children in Israel After
    Shalom Ben-Shimol, M.D. Pediatric Infectious Disease Unit Invasive pneumococcal disease in young children in Israel after sequential Soroka University Medical Center Beer-Sheva, Israel introduction of PCV7 followed by PCV13 [email protected] 1S. Ben-Shimol, 1D. Greenberg, 1N. Givon-Lavi, 2Y. Schlesinger, 3E. Somekh, 4S. Aviner, 5D. Miron 1R. Dagan on behalf of the Israeli Bacteremia and Meningitis Active Surveillance Group* 1The Pediatric Infectious Disease Unit, Soroka University Medical Center, Ben-Gurion University, Beer-Sheva, 2Shaare Zedek Medical Center, Jerusalem, 3Wolfson Medical Center, Holon, 4The Barzilai Medical Center, Ashkelon, 5 The Pediatric Infectious Disease Service, HaEmek Medical Center, Afula Vaccine uptake evaluation Figure 2. Monthly IPD rates in children <2 and 2-4 years old, Israel • Vaccine uptake was measured in the Beer-Sheva district, since traditionally the figure in this district represent the average figures Figure 1. Annual IPD rates in Israeli children <2 years old and 2-4 Years old (July 2004 – June 2013) Abstract in Israel. • Each working day, the first 4 Jewish children and the first 4 Bedouin children seen at the Pediatric Emergency Room (PER) of the Soroka Medical Center in Beer-Sheva, whose parents signed an informed consent were chosen for vaccine uptake study. Their • Background: The 7-valent pneumococcal conjugated vaccine (PCV7) was introduced to the Israeli national immunization plan Maternal Child Health Centers and their Clinics were contacted to receive all vaccination details (which PCV, date of all doses) (NIP) in July 2009 [2, 4, 12 months with a catch-up program] with a rapid reduction of PCV7 serotypes invasive pneumococcal • In June 2009, 2010, 2011 and 2012, the proportion of children 12-23 months old who received ≥2 PCV doses in was 20%, 71%, disease (IPD).
    [Show full text]
  • Survival of Defibrillators the “Real World”
    S4 - Heart Rhythm: Fibrillation & Defibrillation Survival of Defibrillators the “Real World” Michael Geist, Daniel Tarchitzky, Zaev Halfin, Michael Kriwisky, Larisa Rosenshtein, Tal Sela, Leonid Rosenthal, Yoseph Rozenman Heart Institute, Wolfson Medical Center, Holon, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 21 S4 - Heart Rhythm: Fibrillation & Defibrillation Is There Really No Role for EPS Testing in Risk-Stratification of the ICD-Eligible Patient Population? Avraham Wagshal 1,Guy Amit1,Amos Katz1,2, Reuven Ilia 1, Raphael Rosso 3, Sami Viskin 3, Bernard Belhassen 3, Otto Costantini 4, David Rosenbaum4 1 Cardiovascular Disease, Soroka Medical Center, Beer Sheva, 2 Cardiovascular Disease, Barzilai Medical Center, Ashkelon, 3 Cardiovascular Disease, Tel Aviv Medical Center, Tel Aviv, Israel, 4 Cardiovascular Disease, Metro Health Medical Center, Cleveland, USA The 55th Annual Conference of the I.H.S and the I.S.C.S 22 S4 - Heart Rhythm: Fibrillation & Defibrillation Outcome after Implantation of ICD in Patients with Brugada Syndrome: a Multicenter Israeli Study (ISRABRU) Rafael Rosso 1, Aharon Glick 1, Michael Glikson 2, Abraham Wagshal 3, Moshe Swissa 4, Shimon Rosenhek 5, Israel Shetboun 6,Amos Katz7,Therese Fucks8, Munther Boulos 9, Michael Geist 10,Boris Strasberg11, Bernard Belhassen 1 1 Tel-Aviv Sourasky Medical Center, Tel-Aviv, 2 Sheba Medical Center, Tel-Hashomer, 3 Soroka Medical Center, Beer-Sheva, 4 Kaplan Hospital, Rehovot, 5 Hadassa Hospital, Jerusalem, 6 Meir Hospital, Kfar Saba, 7 Barzilai Hospital,
    [Show full text]
  • APF H N P D N a F R C I I E R
    Winter 2011-2012 sicians y a APF h n P d n a F r c i i e r n e A Newsletter of the d m s News American Physicians and Friends A for Medicine in Israel APF - Supporters of Medicine in Israel 2001 Beacon Street, Suite 210, Boston, MA 02135 617-232-5382 [email protected] From the President 2. The Fellowship Awards Program Since 1950 APF has awarded over 1500 fellowship awards totaling over $4 million. As I’ve indicated in past columns, if one looks at the past and current roster of leaders of Israeli medicine, the vast majority of them have been APF fellows in the past. 3. The Student Programs Under the very able leadership of Drs. Alan Menkin and Charles Kurtzer each year up to 40 North American medical It has been a pleasure and an honor to students have gone to Israel for 10 days serve as APF President from 2006 to under the joint sponsorship of Taglit/ 2011. As my term of office draws to a birthright. This has included two days of close I would like to highlight some of the activities with the Israel Defense Force important events of the past five years. Medical Corps, The Israeli Ministry of Health, and the Computer Simulation 1. Emergency Medical Volunteer (EMV) Center at Tel HaShomer Hospital. Courses and Registry In the last five years the EMV Registry 4. Corporate Membership has become fully operational. Working in Under the visionary leadership of Dr. close association with the Israeli Defense Paul Scherer, APF now has Corporate Forces Medical Corps and The Ministry Members and we are grateful for their of Health we now have records of over continued support.
    [Show full text]
  • First Reported Case of Thunderstorm Asthma in Israel
    1 First reported case of Thunderstorm Asthma in Israel 2 3 Yoav Yair1,*, Yifat Yair2, Baruch Rubin2, Ronit Confino-Cohen3, Yosef Rosman3 4 Eduardo Shachar4,& and Menachem Rottem5,& 5 6 1 – Interdisciplinary Center (IDC) Herzliya, School of Sustainability, Israel 7 2 – Hebrew University of Jerusalem, Faculty of Agriculture, food and Environment, Rehovot, Israel 8 3 – Meir Medical Center, Kfar-Saba, Israel 9 4 - Rambam Medical Center, Haifa, Israel 10 5 – Ha'Emek Medical Center, Afula, Israel 11 12 13 14 15 16 Submitted to 17 Natural Hazards and Earth System Sciences 18 April 2019 19 20 Revised 21 September 2019 22 23 24 25 26 27 *Corresponding author 28 Prof. Yoav Yair 29 School of Sustainability, Interdisciplinary Center (IDC) Herzliya 30 P.O. Box 167 Herzliya 4610101 Israel 31 (p) +972-9-9527952 (m) +972-52-5415091 (f) +972-9-9602401 32 Email: [email protected] 33 1 34 Abstract. We report on the first recorded case of thunderstorm asthma in Israel, that 35 occurred during an exceptionally strong Eastern Mediterranean multicell-cell 36 thunderstorm on October 25th 2015. The storms were accompanied by intensive 37 lightning activity, severe hail, downbursts and strong winds followed by intense rain. It 38 was the strongest lightning-producing storm ever recorded by the Israeli Lightning 39 Detection Network since it began operations in 1997. After the passage of the gust front 40 and the ensuing increase in particle concentrations, documented by air-quality sensors, 41 the hospital emergency room presentation records from three hospitals – two in the 42 direct route of the storm (Meir Medical Center in Kfar-Saba and Ha'Emek in Afula) and 43 the other just west of its ground track (Rambam Medical Center in Haifa) showed that 44 the amount of presentation of patients with respiratory problems in the hours 45 immediately following the storm increased compared with the average numbers in the 46 days before., This pattern is in line with that reported by Thien et al., (2018) for the 47 massive thunderstorm asthma epidemic in Melbourne, Australia.
    [Show full text]